Point72 Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Point72 Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-31,900	Closed	-$239K	–	1835
2022 Q2	$239K	Sell	31,900 -958,424	-97%	-$6.75M	﹤0.01%	1268
2022 Q1	$9.01M	Buy	+990,324	New	+$7.63M	0.04%	543
2020 Q4	–	Sell	-183,512	Closed	-$2.16M	–	1208
2020 Q3	$2.16M	Sell	183,512 -666,992	-78%	-$8.12M	0.01%	700
2020 Q2	$12.6M	Buy	850,504 +445,914	+110%	+$6.6M	0.08%	285
2020 Q1	$5.46M	Buy	+404,590	New	+$7.68M	0.04%	372
2019 Q4	–	Sell	-1,412,759	Closed	-$27.2M	–	1332
2019 Q3	$27.2M	Buy	+1,412,759	New	+$32.4M	0.17%	172
2018 Q4	–	Sell	-203,180	Closed	-$12.5M	–	1291
2018 Q3	$12.5M	Buy	203,180 +20,880	+11%	+$1.34M	0.05%	419
2018 Q2	$12.3M	Buy	+182,300	New	+$10.2M	0.05%	398
2017 Q4	–	Sell	-51,900	Closed	-$2.52M	–	1147
2017 Q3	$2.52M	Buy	+51,900	New	+$2.83M	0.01%	649
2015 Q1	–	Sell	-19,900	Closed	-$581K	–	830
2014 Q4	$581K	Buy	+19,900	New	+$505K	﹤0.01%	605

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's AERI Position: Q3 2022 in Review

Point72 Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 31,900 shares — an estimated $239K sold.

Point72 Asset Management first reported a position in AERI in Q4 2014 and held it in 10 quarters. The position peaked at $27.2M in Q3 2019. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Point72 Asset Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Point72 Asset Management sold 31,900 Aerie Pharmaceuticals shares in Q3 2022, an estimated $239K.
Point72 Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 10 quarters.
Point72 Asset Management's Aerie Pharmaceuticals position peaked at $27.2M in Q3 2019.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.